Search
Search
About
Log in
Join
Experiences with
Prialt
Posts
Communities
5,197 public posts
Filter results
Pluvicto / Locametz in the Rocky Mountains yet?
Fighting Prostate Cancer since 2015. Hormone Therapy Clinical trial at Huntsman Cancer Institute in SLC failed after 4 years, now Castrate resistant. Chemo with Docetaxel since Aug 2021, possibly starting to fail. Wanting the new Locametz / Pluvicto treatment before starting Cazabitaxel, but availability
Fighting Prostate Cancer since 2015. Hormone Therapy Clinical trial at Huntsman Cancer Institute in SLC failed after 4 years, now Castrate resistant. Chemo with Docetaxel since Aug 2021, possibly starting to fail. Wanting the new Locametz / Pluvicto treatment before starting Cazabitaxel, but availability
foamhand
in
Advanced Prostate Cancer
2 years ago
Tough Questions
I have never actually asked the MO how long, because I know the answer. Every patient is different, it’s in Gods hands, hard to say with new treatments coming out…but I feel like it is time. My husband has been through hell since diagnosis 18 months ago (advanced metastatic PC). He has gone through
I have never actually asked the MO how long, because I know the answer. Every patient is different, it’s in Gods hands, hard to say with new treatments coming out…but I feel like it is time. My husband has been through hell since diagnosis 18 months ago (advanced metastatic PC). He has gone through
Sipj
in
Advanced Prostate Cancer
2 years ago
Welcoming New Era of Expanded Use of Radiotherapies
Duplicating this for my friends at FPC. This is the short take from Practice Update this morning. Link to the abstract is included. 😃 The three practice changing points included are worth noting. Makes me happy. (Came off of wonderful 3 day backpack around Grand Teton yesterday. Today, back into
Duplicating this for my friends at FPC. This is the short take from Practice Update this morning. Link to the abstract is included. 😃 The three practice changing points included are worth noting. Makes me happy. (Came off of wonderful 3 day backpack around Grand Teton yesterday. Today, back into
MateoBeach
in
Fight Prostate Cancer
2 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Moving into the new area of Expanded use of Radiotherapy
This is the short take from Practice Update this morning. Link to the abstract is included. The three practice changing points included are worth noting. Makes me happy. (Came off of wonderful 3 day backpack around Grand Teton yesterday. Today, back into it in Yellowstone. Pic is of the Grand Teton.
This is the short take from Practice Update this morning. Link to the abstract is included. The three practice changing points included are worth noting. Makes me happy. (Came off of wonderful 3 day backpack around Grand Teton yesterday. Today, back into it in Yellowstone. Pic is of the Grand Teton.
MateoBeach
in
Advanced Prostate Cancer
2 years ago
Phase 2 Clinical Trial of DopaFuse Delivery System
The DopaFuse Delivery System is a patented, intra-oral system that continuously and noninvasively delivers levodopa and carbidopa at a controlled rate for patients with PD. The DopaFuse System consists of an oral retainer, its case, and a prefilled, single-use drug container that continuously releases
The DopaFuse Delivery System is a patented, intra-oral system that continuously and noninvasively delivers levodopa and carbidopa at a controlled rate for patients with PD. The DopaFuse System consists of an oral retainer, its case, and a prefilled, single-use drug container that continuously releases
Farooqji
in
Cure Parkinson's
2 years ago
Rounding the corner of 3 yrs on Keytruda
Hey brothers, I hope your all hanging in there. It’s been awhile since I’ve posted. Hoping for some feedback on this update. read my bio if you want the nitty gritty details. Very brief summary: Dx at 46 stage 4 Gleason 9; ADT; Chemo round 1 (etoposide/cisplatin) concurrent with pelvic radiation;
Hey brothers, I hope your all hanging in there. It’s been awhile since I’ve posted. Hoping for some feedback on this update. read my bio if you want the nitty gritty details. Very brief summary: Dx at 46 stage 4 Gleason 9; ADT; Chemo round 1 (etoposide/cisplatin) concurrent with pelvic radiation;
Chugach
in
Advanced Prostate Cancer
2 years ago
Optical Genome Mapping: a promising new tool to assess genomic complexity - Part Two
Further to https://healthunlocked.com/cllsupport/posts/148409355/optical-genome-mapping-a-promising-new-tool-to-assess-genomic-complexity-in-cll [u]An update from watching the OGM webinar[/u] My impression is that AML cells' DNA has greater structural variation (mutation) than seen in CLL. Some of
Further to https://healthunlocked.com/cllsupport/posts/148409355/optical-genome-mapping-a-promising-new-tool-to-assess-genomic-complexity-in-cll [u]An update from watching the OGM webinar[/u] My impression is that AML cells' DNA has greater structural variation (mutation) than seen in CLL. Some of
bennevisplace
in
CLL Support
2 years ago
still in the hospital…..
Joe is still abed in the hospital, although they have let him get up briefly. (I would have thought movement would help) Partner from onc practice stopped by to say he would get two more doses of chemo (his primary ordered 10, not 6 doses). This onc said that, since Joe developed pneumonia while on
Joe is still abed in the hospital, although they have let him get up briefly. (I would have thought movement would help) Partner from onc practice stopped by to say he would get two more doses of chemo (his primary ordered 10, not 6 doses). This onc said that, since Joe developed pneumonia while on
Cateydid
in
Advanced Prostate Cancer
2 years ago
EXCITING! .... Volunteer now for Phase 3 Study!
[u][i]Phase 3 Trial now recruiting for AnnovisBio.com[/i][/u]
"Buntanetap
(previously known as ANVS401 or Posiphen) is our lead compound. It is a translational inhibitor of neurotoxic aggregating proteins (TINAPs). Different from monoclonal antibody therapies, buntanetap is an [i]
orally available
[u][i]Phase 3 Trial now recruiting for AnnovisBio.com[/i][/u]
"Buntanetap
(previously known as ANVS401 or Posiphen) is our lead compound. It is a translational inhibitor of neurotoxic aggregating proteins (TINAPs). Different from monoclonal antibody therapies, buntanetap is an [i]
orally available
PDWarrior1900
in
Cure Parkinson's
2 years ago
First Patient Dosed in Phase 3 Trial of Buntanetap for Early Parkinson's
The first patient has been dosed in a clinical trial testing Annovis Bio’s buntanetap as an oral therapy for early-stage Parkinson’s disease, the company announced. The Phase 3 clinical trial (NCT05357989) got started shortly after the U.S. Food and Drug Administration (FDA) gave the company the green
The first patient has been dosed in a clinical trial testing Annovis Bio’s buntanetap as an oral therapy for early-stage Parkinson’s disease, the company announced. The Phase 3 clinical trial (NCT05357989) got started shortly after the U.S. Food and Drug Administration (FDA) gave the company the green
Farooqji
in
Cure Parkinson's
2 years ago
I'm on Day #157 of my O.M.A.D. (one meal a day) diet ... Check out this link
I'm using O.M.A.D. (one meal a day) to lose weight (!) and promote autophagy (your body's natural way to cleanse itself of dead cells). I just found this interesting website on autophagy. STAY STRONG! There are hundreds of international clinical trials going on RIGHT NOW! I'm confident that a 'MIRACE
I'm using O.M.A.D. (one meal a day) to lose weight (!) and promote autophagy (your body's natural way to cleanse itself of dead cells). I just found this interesting website on autophagy. STAY STRONG! There are hundreds of international clinical trials going on RIGHT NOW! I'm confident that a 'MIRACE
PDWarrior1900
in
Cure Parkinson's
2 years ago
Measuring T4/3 metabolites to address personal individuality
This paper is not directly addressing T4 and T3 metabolism in subjects but is assessing linkages between the various reactions and products. It concludes that as regards pharmacokinetics of change, we are all individual in our actions, and of course leading on to individuality of response to T4 treatment
This paper is not directly addressing T4 and T3 metabolism in subjects but is assessing linkages between the various reactions and products. It concludes that as regards pharmacokinetics of change, we are all individual in our actions, and of course leading on to individuality of response to T4 treatment
diogenes
in
Thyroid UK
2 years ago
Phase 1 study SBRT for bone metastases in oligometastatic patients. So far, "few toxicity events and high local control rate"
stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis Francesco Deodato, Donato Pezzulla, Savino Cilla, Milena Ferro, C Romano, P Bonome, Milly Buwenge, A Zamagni, L Strigari, Vincenzo Valentini, Alessio Giuseppe Morganti, Gabriella
stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis Francesco Deodato, Donato Pezzulla, Savino Cilla, Milena Ferro, C Romano, P Bonome, Milly Buwenge, A Zamagni, L Strigari, Vincenzo Valentini, Alessio Giuseppe Morganti, Gabriella
Graham49
in
Advanced Prostate Cancer
2 years ago
This is worth your time to look at ... Benedlife.com says it has clinical proof their supplement (take with your regular PD meds) WORKS!
I just checked their website. Those cost is $165 a month for their supplement. From: https://www.frontiersin.org/articles/10.3389/fnut.2021.650053/full "Conclusion:[i]
The present study demonstrated that PS128 supplementation for 12 weeks with constant anti-parkinsonian medication improved the
I just checked their website. Those cost is $165 a month for their supplement. From: https://www.frontiersin.org/articles/10.3389/fnut.2021.650053/full "Conclusion:[i]
The present study demonstrated that PS128 supplementation for 12 weeks with constant anti-parkinsonian medication improved the
PDWarrior1900
in
Cure Parkinson's
2 years ago
177LU-PNT2002 PSMA THERAPY vs Pluvicto
It is my understanding this new drug presently under clinical trials is supposed to be a future alternative to Pluvicto... can anyone shed some light about this new drug and how it competes with Pluvicto? Thanks
It is my understanding this new drug presently under clinical trials is supposed to be a future alternative to Pluvicto... can anyone shed some light about this new drug and how it competes with Pluvicto? Thanks
Ollie1948
in
Advanced Prostate Cancer
2 years ago
Side Effects of Niraparib (ZEJULA)?
While I await the results of my genetic test to see if I have the DNA repair defect to allow me to participate in the AMPLITUDE clinical trial, I have been looking at the SEs for Niraparib and they don’t look very pleasant, so I wondered if anyone has used it and has personal experience to share?
While I await the results of my genetic test to see if I have the DNA repair defect to allow me to participate in the AMPLITUDE clinical trial, I have been looking at the SEs for Niraparib and they don’t look very pleasant, so I wondered if anyone has used it and has personal experience to share?
Benkaymel
in
Advanced Prostate Cancer
2 years ago
Clinical trails
Going to my very first visit for my first clinical trial soon. PSA is at .3 and it seems that the zytiga is starting to fail. PSA was over 500 5 years ago and has served me well. Just wondering how Clinical Trails work and are they worth it.
Going to my very first visit for my first clinical trial soon. PSA is at .3 and it seems that the zytiga is starting to fail. PSA was over 500 5 years ago and has served me well. Just wondering how Clinical Trails work and are they worth it.
lincolnj8
in
Advanced Prostate Cancer
2 years ago
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
[i]
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
[/i] BERWYN, Pa., August 24, 2022 -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases, announced
[i]
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
[/i] BERWYN, Pa., August 24, 2022 -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases, announced
PDWarrior1900
in
Cure Parkinson's
2 years ago
Litifilimab Lessens Skin Disease Activity in Lupus, Trial Data Show
Litifilimab Lessens Skin Disease Activity in Lupus, Trial Data ShowTherapy known as BIIB059 led to 'huge improvements,' researchers say: Marta Figueiredo, PhD | August 22, 2022 Biogen’s experimental therapy litifilimab, also called BIIB059, significantly reduced skin disease activity in adults with
Litifilimab Lessens Skin Disease Activity in Lupus, Trial Data ShowTherapy known as BIIB059 led to 'huge improvements,' researchers say: Marta Figueiredo, PhD | August 22, 2022 Biogen’s experimental therapy litifilimab, also called BIIB059, significantly reduced skin disease activity in adults with
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
2 years ago
Met-directed therapy beneficial when less than five mets
From International Journal of Radiation Oncology, August 16, 2 022 In this review, the authors outline the evidence to date from clinical trials assessing the utility of radiotherapy in patients with oligometastatic prostate cancer. Primary prostate radiation in the de novo metastatic setting prolongs
From International Journal of Radiation Oncology, August 16, 2 022 In this review, the authors outline the evidence to date from clinical trials assessing the utility of radiotherapy in patients with oligometastatic prostate cancer. Primary prostate radiation in the de novo metastatic setting prolongs
Purple-Bike
in
Advanced Prostate Cancer
2 years ago
1
...
46
47
48
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1288 results
Cure Parkinson's
651 results
CLL Support
625 results
View top 10 communities
Sort by
Most Relevant
Newest